Moreover, SCPE could effectively inhibit the formation of NAFLD by inhibition of LXR-α, SREBP-1c and FAS genes expression, and modulate the structural alteration of gut microbiota in obesity mice. This evidence concerns the gene SREBF1 and metabolic dysfunction-associated steatotic liver disease.